Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Dec;27(12):1163-73.
doi: 10.1002/humu.20412.

Molecular approaches in the diagnosis of primary immunodeficiency diseases

Affiliations
Review

Molecular approaches in the diagnosis of primary immunodeficiency diseases

Maurizio Costabile et al. Hum Mutat. 2006 Dec.

Abstract

Over 120 inherited primary immunodeficiency diseases (PIDs) are known to exist. The genes responsible for many of these diseases have also been identified. Recent advances in diagnostic procedures have enabled these to be identified earlier and appropriately treated. While a number of approaches are available to identify mutations, direct sequencing remains the gold standard. This approach identifies the exact genetic change with substantial precision. We suggest that a sensitive and economical approach to mutation detection could be the direct sequencing of cDNA followed by the confirmatory sequencing of the corresponding exon. While screening techniques such as single-stranded conformation polymorphism (SSCP), heteroduplex analysis (HA), denaturing gradient gel electrophoresis (DGGE), and denaturing high-performance liquid chromatography (dHPLC) have proven useful, each has inherent advantages and disadvantages. We discuss these advantages and disadvantages and also discuss the potential of future sequencing technologies such as pyrosequencing, combinatorial sequencing-by-hybridization, multiplex polymerase colony (polony), and resequencing arrays as tools for future mutation detection. In addition we briefly discuss several high-throughput SNP detection technologies.

PubMed Disclaimer

References

    1. Ahmadian A, Lundeberg J, Nyren P, Uhlen M, Ronaghi M. 2000. Analysis of the p53 tumor suppressor gene by pyrosequencing. Biotechniques 28:140–144; 146–147. - PubMed
    1. Ahmadian A, Ehn M, Hober S. 2006. Pyrosequencing: history, biochemistry and future. Clin Chim Acta 363:83–94. - PubMed
    1. Amedei A, Romagnani C, Benagiano M, Azzurri A, Fomia F, Torrente F, Plebani A, D'Elios MM, Del Prete G. 2001. Preferential Th1 profile of T helper cell responses in X‐linked (Bruton's) agammaglobulinemia. Eur J Immunol 31:1927–1934. - PubMed
    1. Aoshima M, Nunoi H, Shimazu M, Shimizu S, Tatsuzawa O, Kenney RT, Kanegasaki S. 1996. Two‐exon skipping due to a point mutation in p67‐phox‐deficient chronic granulomatous disease. Blood 88:1841–1845. - PubMed
    1. Bai X, Li Z, Jockusch S, Turro NJ, Ju J. 2003. Photocleavage of a 2‐nitrobenzyl linker bridging a fluorophore to the 5′ end of DNA. Proc Natl Acad Sci USA 100:409–413. - PMC - PubMed

MeSH terms

Substances